8-K: Know Labs Pivots to Bitcoin Treasury Strategy with Controlling Investment from Fintech Veteran Greg Kidd

Sentiment:

Strategic Investment and Corporate Restructuring


Know Labs, Inc. announces a definitive agreement for Goldeneye 1995 LLC, an affiliate of Greg Kidd, to acquire a controlling interest, pivoting the company to a Bitcoin treasury strategy and appointing Kidd as CEO and Chairman.

Capital raiseKnow Labs, Inc. entered into a Securities Purchase Agreement with Goldeneye 1995 LLC for a private placement of common stock.The Buyer will purchase shares for an aggregate price consisting of 1,000 Bitcoin and a cash amount between $12 million and $15 million.The per share purchase price for the common stock is $0.335.The cash component of the capital raise is intended to retire existing debt, redeem outstanding preferred equity, and provide additional working capital.J.V.B Financial Group, LLC (the Banker), acting as the Buyer's exclusive financial advisor, will receive a transaction fee in the form of shares of Common Stock equal to 2% of the post-Closing Company Common Stock.The issuance and sales of these securities are exempt from registration under the Securities Act, pursuant to Section 4(a)(2) thereof.

Summary

  • Know Labs, Inc. (KNW) has entered into a Securities Purchase Agreement with Goldeneye 1995 LLC, an affiliate of fintech investor Greg Kidd, for a private placement.
  • The Buyer will acquire a controlling interest in Know Labs by purchasing common stock for an aggregate price of 1,000 Bitcoin plus a cash amount ranging from $12 million to $15 million.
  • The per share purchase price for the common stock is $0.335.
  • Upon the closing of the transaction, Greg Kidd will assume the roles of Chief Executive Officer and Chairman of the Board of Directors.
  • The Company will adopt a Bitcoin treasury strategy, aiming to provide investors with significant economic exposure to this digital asset.
  • Founder Ron Erickson will transition to President of a new division focused on proprietary diagnostic research and will serve as Vice Chairman of the Board.
  • The transaction received unanimous approval from the Know Labs Board of Directors and is anticipated to close in the third quarter of 2025, contingent on shareholder approval and other customary closing conditions.
  • At closing, the implied entry multiple of net asset value (mNAV) is 1.22x, with Bitcoin holdings projected to represent 82% of the market capitalization (assuming a Bitcoin price of $105,000).
  • Existing Series C and Series D Convertible Preferred Stock holders are required to convert their shares into Common Stock, and Series H Preferred Stock will be redeemed.
  • Employment agreements for Peter Conley (CFO) and Ronald Erickson (CEO) have been amended; Conley's employment will terminate upon closing, and Erickson's annual base salary will be reduced from $500,000 to $375,000, with a narrowed 'Good Reason' definition for resignation.
  • Certain stockholders, collectively holding approximately 37% of the total voting power, have entered into Voting and Support Agreements, committing to vote in favor of the transaction.

Sentiment

Score: 8

Explanation: The transaction provides a substantial capital injection and a clear strategic pivot into a high-growth, high-interest sector (Bitcoin treasury strategy) led by a prominent figure in fintech. While there are executive changes and standard risks, the overall tone and stated benefits suggest a strong positive outlook for the company's future, especially for investors seeking exposure to digital assets.

Positives

  • The transaction provides a substantial capital injection, including 1,000 Bitcoin and $12 million to $15 million in cash, which will be used to retire existing debt, redeem preferred equity, and provide working capital.
  • The strategic pivot to a Bitcoin treasury strategy offers investors direct economic exposure to a highly attractive digital asset, potentially generating sustainable growth and long-term shareholder value.
  • The incoming leadership of Greg Kidd, a prominent fintech investor and former Ripple Chief Risk Officer, brings deep expertise in digital assets and a proven track record of early investments in major tech companies.
  • The transaction received unanimous approval from the Know Labs Board of Directors, indicating strong internal alignment on the new strategic direction.
  • The Company's commitment to continue its proprietary diagnostic research under a new division led by founder Ron Erickson ensures continuity in its original technological focus.
  • Significant shareholder support is already secured, with stockholders representing approximately 37% of the total voting power committed to voting in favor of the transaction.

Negatives

  • Peter Conley's employment as Chief Financial Officer will terminate automatically upon the consummation of the transaction.
  • Ronald Erickson's annual base salary will be reduced from $500,000 to $375,000, and the definition of 'Good Reason' for his resignation has been amended to exclude a material diminution in his office, title, or duties.
  • The transaction is subject to various closing conditions, including shareholder approval, conversion of preferred stock, termination of certain contracts and liens, and repayment of indebtedness, which introduce execution risk.

Risks

  • Fluctuations in the market price of Bitcoin and associated impairment charges that the Company may incur if the market price of Bitcoin falls below its carrying value on the balance sheet.
  • Uncertainties and volatility in interest rates could impact the Company's financial condition.
  • The Company's ability to achieve and maintain profitability in the future, particularly with the new strategic direction.
  • Risks related to the timing of the proposed transaction, including potential delays in closing.
  • The risk that a condition of closing of the proposed transaction may not be satisfied, or that the closing might otherwise not occur.
  • The impact of the evolving regulatory environment on the Company's business and complexities with compliance, including changes in securities laws or other regulations related to digital assets.
  • Changes in the accounting treatment relating to the Company's Bitcoin holdings could affect reported financial results.
  • The Company's ability to effectively respond to general economic conditions.
  • Challenges in managing growth effectively and uncertainties regarding the development and expansion of its new business model.
  • The Company's ability to access sufficient sources of capital, including debt financing, to fund operations and growth.
  • The risk of the Common Stock being delisted or suspended from trading on the Principal Market (NYSE American LLC).
  • Potential for stockholder litigation challenging the validity or terms of the transaction.

Future Outlook

The Company intends to pivot to a Bitcoin treasury strategy, with management planning to use the multiple of net asset value (mNAV) metric to measure investor valuation relative to Bitcoin holdings. This approach is expected to generate sustainable growth and long-term shareholder value by deploying a Bitcoin yield generation strategy in public markets. The Company's non-invasive diagnostic research will continue under a newly formed division.

Management Comments

  • "I'm thrilled to deploy a Bitcoin treasury strategy with the support of a forward-looking organization like Know Labs at a time when market and regulatory conditions are particularly favorable. We believe this approach will generate sustainable growth and long-term shareholder value." Greg Kidd
  • "Partnering with Greg Kidd marks a pivotal next chapter for Know Labs. We look forward to continuing our research in non-invasive medical technology. Greg's visionary leadership positions Know Labs for a bold future." Ron Erickson

Industry Context

This announcement signifies a notable trend of public companies integrating digital assets, specifically Bitcoin, into their treasury strategies. This move aligns Know Labs with a growing number of firms seeking to leverage Bitcoin's potential as a store of value and a means of generating yield, particularly in a favorable market and regulatory environment for digital assets. It represents a significant strategic shift from its core non-invasive health monitoring focus, diversifying its business model into the fintech and digital asset space, potentially attracting a new investor base interested in cryptocurrency exposure through a publicly traded entity.

Comparison to Industry Standards

  • The implied entry mNAV multiple of 1.22x for Know Labs, with Bitcoin holdings representing 82% of market capitalization (assuming a Bitcoin price of $105,000), can be compared to other public companies that have adopted Bitcoin treasury strategies, such as MicroStrategy (MSTR) or Tesla (TSLA).
  • MicroStrategy, for instance, is known for its aggressive Bitcoin acquisition strategy, and its stock valuation is often closely tied to its Bitcoin holdings, frequently trading at a premium or discount to its net asset value. While specific mNAV multiples for direct comparison are not provided in the document, the stated 1.22x multiple suggests a slight premium ascribed to Know Labs' valuation relative to its Bitcoin holdings at entry.
  • To fully assess this, a detailed comparison would require analyzing the historical and current mNAV multiples of these comparable companies, considering factors like their operational businesses, debt levels, and the proportion of their market cap represented by digital assets. The document implies that this valuation is favorable for the entry point into the Bitcoin treasury strategy.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerPeter ConleyN/AUpon consummation of the transactionEmployment term will terminate automatically upon closing of the transaction contemplated by the Securities Purchase Agreement.
Chief Executive Officer and Chairman of the BoardRonald Erickson (CEO)Greg KiddUpon consummation of the transactionAcquisition of a controlling interest by Greg Kidd's affiliate, Goldeneye 1995 LLC, leading to a new strategic direction and leadership.
President of new division (diagnostic research) and Vice Chairman of the BoardChief Executive Officer and Chairman of the BoardRonald EricksonUpon consummation of the transactionStrategic shift and new leadership structure following Greg Kidd's investment, allowing Mr. Erickson to focus on the Company's core diagnostic research.
Board of Directors MemberN/AFive members (one designated by Company, four by Buyer)Immediately after Closing DateNew board composition as part of the transaction, reflecting the change in control.
OfficersN/ATo be designated by BuyerPrior to ClosingNew officer appointments as part of the transaction, aligning management with the new strategic direction.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Company Board will be comprised of five members, with one member designated by the Company and four members designated by Buyer, to be elected at the Company Stockholder Meeting.Immediately after Closing DateThis change grants significant control over the Board to the new controlling investor, Goldeneye 1995 LLC, through its affiliate Greg Kidd, aligning governance with the new strategic direction.
Officer AppointmentsThe officers of the Company shall be designated by Buyer prior to Closing.Prior to ClosingBuyer will gain control over key executive positions, ensuring that management is aligned with the new strategic objectives and operational focus.
Certificate of Incorporation AmendmentAn amendment to the Company Charter will be proposed to increase the number of authorized shares of Common Stock and make other mutually agreeable changes, subject to shareholder approval.Upon Closing, after shareholder approvalThis amendment facilitates the issuance of new shares to the Buyer and provides the Company with greater flexibility for future capital actions or adjustments to its corporate structure.
Equity Incentive Plan Amendment (Potential)If requested by Buyer, a proposal to increase the number of authorized Common Stock available under the Company's 2021 equity incentive plan will be put to shareholders.Upon Closing, after shareholder approval (if requested)This allows for potential future equity compensation to attract and retain talent aligned with the new management and strategic goals, supporting the Company's long-term growth.
Employment Agreement AmendmentsAmendments to employment agreements for Ronald Erickson and Peter Conley, including a salary reduction for Erickson and termination for Conley, effective upon transaction consummation.Upon consummation of the transactionRestructures executive compensation and roles to align with the new ownership and strategic direction, reflecting the shift in leadership and operational focus.

Legal Proceedings

  • The Company states there is no Legal Proceeding before or by any Governmental Body, pending or, to the Company's knowledge, threatened in writing against or affecting the Company or any of its Subsidiaries, the Common Stock or any of the Company's or its Subsidiaries officers or directors, in their capacities as such.
  • The Company agrees to conduct and control the settlement and defense of any stockholder litigation against the Company or its directors related to the transaction, requiring Buyer's prior written consent for any settlement prior to closing.

Related Party Transactions

  • The Securities Purchase Agreement is with Goldeneye 1995 LLC, an affiliate of Greg Kidd, who will become the Company's Chief Executive Officer and Chairman of the Board.
  • Certain stockholders of the Company, collectively representing approximately 37% of the total voting power, have entered into Voting and Support Agreements with the Company and the Buyer, committing to vote in favor of the transaction.
  • J.V.B Financial Group, LLC (the Banker), acting as the Buyer's exclusive financial advisor, will receive a transaction fee in the form of Fee Shares (Common Stock equal to 2% of the post-Closing Company Common Stock).

Stakeholder Impact

  • **Shareholders**: Will experience significant dilution from the issuance of new shares to the Buyer. However, they gain potential upside from the strategic pivot to a Bitcoin treasury strategy and the expertise of new leadership in digital assets. Shareholder approval is required for the transaction.
  • **Preferred Shareholders**: Holders of Series C and Series D Convertible Preferred Stock will convert their shares into Common Stock, and Series H Preferred Stock will be redeemed, simplifying the capital structure.
  • **Employees**: Peter Conley's employment as CFO will terminate. Ronald Erickson's role will change to President of a new division and Vice Chairman, with a reduction in base salary. The new management team under Greg Kidd will lead the company's strategic direction.
  • **Creditors**: Existing debt will be retired as part of the cash component of the purchase price, which is beneficial for the Company's balance sheet.
  • **Management**: Significant changes in leadership roles and compensation structure, with Greg Kidd taking the helm and Ron Erickson transitioning to a new strategic role.

Next Steps

  • The Company will file a proxy statement on Schedule 14A with the SEC.
  • The Company will call and hold a stockholder meeting to approve the issuance of Common Shares, the resulting change of control, an amendment to the Company Charter (to increase authorized shares and other mutually agreeable changes), the election of new directors, and potentially an increase in authorized Common Stock under the 2021 equity incentive plan.
  • The Company will file the Company Charter Amendment with the Secretary of State of Nevada on or prior to the Closing.
  • Current holders of Series C and Series D Convertible Preferred Stock must convert all shares into Common Stock.
  • The Series H Preferred Stock will be redeemed.
  • Certain Company contracts and liens must be terminated.
  • The Closing Indebtedness must be repaid.
  • The Common Stock must be designated for quotation or listed on NYSE American LLC and not suspended from trading.
  • The Company must obtain all necessary governmental, regulatory, or third-party consents and approvals.
  • The Company will file a Registration Statement on Form S-1 covering the resale of all Registrable Securities within 30 days of the Closing.
  • The Company will use its best efforts to have the Registration Statement declared or deemed effective by the SEC as soon as practicable, but no later than 30-60 days after filing.
  • The Company will file a Form D with the SEC and comply with applicable state Blue Sky laws.
  • The Company will secure the listing of all Registrable Securities upon each national securities exchange or automated quotation system where Common Stock is listed.

Key Dates

DateDescription
March 22, 2018Date of the original Amended Employment Agreement between Know Labs, Inc. and Ronald Erickson.
May 13, 2022Date of the original Employment Agreement between Know Labs, Inc. and Peter Conley.
September 30, 2024Fiscal year end for Know Labs' most recent Annual Report on Form 10-K.
November 14, 2024Date Know Labs' Annual Report on Form 10-K for the fiscal year ended September 30, 2024, was filed with the SEC.
December 31, 2024Date of the Engagement Letter between an affiliate of Buyer and J.V.B. Financial Group, LLC.
April 7, 2025Date of the Mutual Confidentiality Agreement between Hard Yaka Ventures Management Co., LLC and the Company.
May 30, 2025Date of the Consent and Waiver of Rights under the Securities Purchase Agreement between the Company and Lind Global Fund II LP.
June 5, 2025Date of Amendment No. 1 to the Amended Employment Agreement for Ronald Erickson. Date of Amendment No. 1 to the Employment Agreement for Peter Conley. Date of the Securities Purchase Agreement between Know Labs, Inc. and Goldeneye 1995 LLC. Date of the Voting and Support Agreements.
June 6, 2025Date of the 8-K filing and the press release announcing the transaction.
Third Quarter 2025Expected closing period for the transaction.
October 3, 2025End Date for the transaction closing; if the transaction is not consummated by this date, the amendments to the employment agreements for Ronald Erickson and Peter Conley will become void.

Recommendation

strong buy

Keywords

Know Labs, KNW, Goldeneye 1995 LLC, Greg Kidd, Bitcoin treasury strategy, private placement, controlling interest, fintech, digital assets, cryptocurrency, SEC filing, 8-K, corporate governance, executive change, shareholder approval, non-invasive health monitoring, strategic pivot, capital raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.